DOCSLIB.ORG

Topic 5 Nucleic Acids As Drug Targets

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Topic 5 Nucleic Acids As Drug Targets Topic 5 Nucleic Acids as Drug Targets Nucleic Acids-Chapter 7 Patrick and Corey 187, 188, 193-194, 198-199 1. DEOXYRIBONUCLEIC ACID (DNA) 1.2 Secondary Structure - Double Helix Thymine Adenine o O 10A P Me O H2N N O G C O O A T O 3' TA P N T A O NH N G C O Major G C N N 5' groove O O TA 5' O T A O T A NH O O P Minor A T 2 N O groove 3' A T o O T A 34A C G O N O G C P O N HN 3' TA O N N T A O G C 5' 5' O H2N G C O GC O T A A T 3' Cytosine Guanine O P C G O O TA O P O T A O DNA DOUBLE HELIX Base Pairing G-C base pairing involves 3 H-bonds A-T base pairing involves 2 H-bonds 1. DEOXYRIBONUCLEIC ACID (DNA) 1.3 Tertiary Structure • Double helix coils into a 3D shape - supercoiling • Double helix has to unravel during replication • Unravelling leads to strain • Relieved by enzyme catalysed cutting and repair of DNA chain • Important to the activity of the quinolone and fluoroquinolone antibacterial agents which act as enzyme inhibitors 2. RIBONUCLEIC ACID (RNA) 2.1 Primary structure • Similar to DNA with the following exceptions • Ribose is used instead of deoxyribose • Uracil is used rather than thymine O HOCH2 O OH H H HN H H OH OH O N H Ribose Uracil 2. RIBONUCLEIC ACID (RNA) 2.2 Secondary structure • Single stranded • Some regions of helical secondary structure exist due to base pairing within the same strand (see t-RNA) • Adenine pairs to uracil; guanine pairs to cytosine 2. RIBONUCLEIC ACID (RNA) 2.3 Tertiary structure • Three types of RNA are involved in protein synthesis: • Messenger RNA (mRNA) Relays the code for a protein from DNA to the protein production site • Transfer RNA (tRNA) The adapter unit linking the triplet code on mRNA to specific amino acids • Ribosomal RNA (rRNA) Present in ribosomes (the production site for protein synthesis). Important both structurally and catalytically 2. RIBONUCLEIC ACID (RNA) 3'p 2.3 Tertiary structure end A AMINO 5'pACID C end C Base Pairing A G C mI Methylinosine G C G U I Inosine C G UH2 Dihydrouridine G C T Ribothymidine U U A U U Ps Pseudouridine G G G C U A UH U A G G C C mG Methylguanosine 2 C G C G mG G Amino C acid U C C G G C m2G Dimethylguanosine G A G C G C m2G C T Ps G UH2 C G UH2 A G U A t-RNA C G C G C G Yeast alanine-tRNA ACG U Ps Anticodon U mI binding region I C G ANTICODON for m-RNA Anticodon - the 3 bases are specific for the attached amino acid - base pair to the complementary triplet code on m- RNA (the codon) 2. RIBONUCLEIC ACID (RNA) 2.5 Translation - protein synthesis PEPTIDE NH NH2 R C H R' C H O C O C HO O HO O H H H H H H H H OH OH O O P O PEPTIDE Adenine O O P O Adenine O O NH t RNA t RNA R C H O C Transfer of NH growing peptide chain to next R' C H amino acid HO OH O C H H H H HO O OH H H H H Adenine O O P O OH O Adenine O O P O t RNA O t RNA 2. RIBONUCLEIC ACID (RNA) 2.5 Translation - protein synthesis mRNA Overview Ribosome DNA Amino acid tRNA mRNA Translation Transcription Nucleus Protein Contents Part 2: Section 7.3 (Drugs acting on DNA) 3. Drugs acting on DNA 3.1. Intercalating agents - Topoisomerase II - Example – Proflavine 3.2. Alkylating agents 3.3. Chain cutters 3. DRUGS ACTING ON DNA 3.1 Intercalating agents Mechanism of action • Contain planar aromatic or heteroaromatic ring systems • Planar systems slip between the layers of nucleic acid pairs and disrupt the shape of the helix • Preference is often shown for the minor or major groove • Intercalation prevents replication and transcription • Intercalation inhibits topoisomerase II- see Doxorubicin, p.198 Corey. 3. DRUGS ACTING ON DNA Topoisomerase II • Relieves the strain in the DNA helix by temporarily cleaving the DNA chain and crossing an intact strand through the broken strand Topo II Tyr 5' 3' 3' 5' DNA • Tyrosine residues in the enzyme are involved in the chain breaking process • The residues form covalent bonds to DNA 3. DRUGS ACTING ON DNA Topoisomerase II • Relieves the strain in the DNA helix by temporarily cleaving the DNA chain and crossing an intact strand through the broken strand Topo II Tyr 5' 3' 3' 5' DNA Tyr Topo II • Tyrosine residues in the enzyme are involved in the chain breaking process • The residues form covalent bonds to DNA • The enzyme pulls the chains apart to create a gap 3. DRUGS ACTING ON DNA Topoisomerase II • Relieves the strain in the DNA helix by temporarily cleaving the DNA chain and crossing an intact strand through the broken strand Topo II Tyr DNA Tyr Topo II • Tyrosine residues in the enzyme are involved in the chain breaking process • The residues form covalent bonds to DNA • The enzyme pulls the chains apart to create a gap • The intact strand of DNA is passed through the gap 3. DRUGS ACTING ON DNA Topoisomerase II • Relieves the strain in the DNA helix by temporarily cleaving the DNA chain and crossing an intact strand through the broken strand 3 Topo II Tyr 5' 3' 3' 5' Tyr Topo II • Tyrosine residues in the enzyme are involved in the chain breaking process • The residues form covalent bonds to DNA • The enzyme pulls the chains apart to create a gap • The intact strand of DNA is passed through the gap • The break is resealed 3. DRUGS ACTING ON DNA Topoisomerase II • Relieves the strain in the DNA helix by temporarily cleaving the DNA chain and crossing an intact strand through the broken strand 4 Topo II Tyr 5' 3' 3' 5' • Tyrosine residues in the enzyme are involved in the chain breaking process • The residues form covalent bonds to DNA • The enzyme pulls the chains apart to create a gap • The intact strand of DNA is passed through the gap • The break is resealed 3. DRUGS ACTING ON DNA Topoisomerase II Mechanism of chain cutting 5' Base O H H 5' Base O H H H H TopoII HO H H H TopoII HO Tyr Tyr O H O O P O P O Base O O Base O O O H H H H H H H H O H O H 3' 3' 3. DRUGS ACTING ON DNA 3.1 Intercalating agents Examples Planar rings N-Me-Gly N-Me-Gly O OH O N-Me-L-Val L-Pro N-Me-L-Val L-Pro CH2OH D-Val D-Val O O OH C C C O C O H C C H H H Me Me OMe O OH H O NH NH C O O C H O N NH2 H Me H H H HO O O Planar rings H NH3 CH3 CH3 Dactinomycin Doxorubicin (Adriamycin) Extra binding to sugar Extra binding to sugar phosphate phosphate backbone by NH3 backbone by cyclic peptide 3. DRUGS ACTING ON DNA 3.2 Alkylating agents • Contain highly electrophilic groups • Form covalent bonds to nucleophilic groups in DNA (e.g. 7-N of guanine) • Prevent replication and transcription • Useful anti-tumour agents • Toxic side effects (e.g. alkylation of proteins) Example Mechlorethamine (nitrogen mustard) Cl CH3 N Cl 3. DRUGS ACTING ON DNA 3.2 Alkylating agents Cross linking X X X X Nu Nu Nu Nu Nu Nu Nu Nu Intrastrand cross linking Interstrand cross linking 3. DRUGS ACTING ON DNA 3.2 Alkylating agents Mechanism of action DNA DNA H G = Guanine O N NH2 Cl H O N NH2 N + N N N N CH3 N CH3 N CH3 N N G Cl Cl Mechlorethamine Aziridine ion Cl N N NH2 N N NH2 N NH N NH G O O DNA DNA H O N H NH2 O N NH2 N N N Crosslinked DNA N N CH N 3 + N N N N NH2 N N NH2 CH N NH N NH 3 O O 3. DRUGS ACTING ON DNA 3.2 Alkylating agents Mechlorethamine analogues Cl Cl O N N HN Cl Cl O N H Aromatic ring - e withdrawing effect Uracil mustard N is less nucleophilic Used vs leukemia Less reactive alkylating agent Attached to a nucleic acid building Selective for stronger nucleophiles block (e.g. guanine) Concentrated in fast growing cells (tumours) Some selectivity 3. DRUGS ACTING ON DNA 3.2 Alkylating agents Cisplatin Mitomycin C O CH2OCONH2 Cl NH3 H2N Pt OMe Cl NH3 Me N NH O Binds to DNA in regions rich in guanine Converted to alkylating agent in the units body Intrastrand links rather than interstrand Inhibits transcription H O OH O CH2OCONH2 CH2OCONH2 CH2OCONH2 H N H2N OMe H2N OMe 2 -MeOH Reduction N NH Me N NH Me N NH Me H O OH OH O H C NH2 H O O CH OCONH OH 2 2 CH2 H N H N-DNA -H + 2 H2N 2 NH-DNA Ring H2N-DNA opening N Me Me N NH2 NH OH OH 2 Alkylating agent O Guanine HN N N NH N NH-DNA OH OH CH2 O CH2 Guanine H2N H N HN N 2 NH NH-DNA -CO N N 2 N -NH Me 3 Me N NH2 NH2 OH OH Crosslinked DNA 3.
Load more

Recommended publications
  • Chapter 23 Nucleic Acids
    7-9/99 Neuman Chapter 23 Chapter 23 Nucleic Acids from Organic Chemistry by Robert C. Neuman, Jr. Professor of Chemistry, emeritus University of California, Riverside [email protected] <http://web.chem.ucsb.edu/~neuman/orgchembyneuman/> Chapter Outline of the Book ************************************************************************************** I. Foundations 1. Organic Molecules and Chemical Bonding 2. Alkanes and Cycloalkanes 3. Haloalkanes, Alcohols, Ethers, and Amines 4. Stereochemistry 5. Organic Spectrometry II. Reactions, Mechanisms, Multiple Bonds 6. Organic Reactions *(Not yet Posted) 7. Reactions of Haloalkanes, Alcohols, and Amines. Nucleophilic Substitution 8. Alkenes and Alkynes 9. Formation of Alkenes and Alkynes. Elimination Reactions 10. Alkenes and Alkynes. Addition Reactions 11. Free Radical Addition and Substitution Reactions III. Conjugation, Electronic Effects, Carbonyl Groups 12. Conjugated and Aromatic Molecules 13. Carbonyl Compounds. Ketones, Aldehydes, and Carboxylic Acids 14. Substituent Effects 15. Carbonyl Compounds. Esters, Amides, and Related Molecules IV. Carbonyl and Pericyclic Reactions and Mechanisms 16. Carbonyl Compounds. Addition and Substitution Reactions 17. Oxidation and Reduction Reactions 18. Reactions of Enolate Ions and Enols 19. Cyclization and Pericyclic Reactions *(Not yet Posted) V. Bioorganic Compounds 20. Carbohydrates 21. Lipids 22. Peptides, Proteins, and α−Amino Acids 23. Nucleic Acids **************************************************************************************
    [Show full text]
  • Alternative Biochemistries for Alien Life: Basic Concepts and Requirements for the Design of a Robust Biocontainment System in Genetic Isolation
    G C A T T A C G G C A T genes Review Alternative Biochemistries for Alien Life: Basic Concepts and Requirements for the Design of a Robust Biocontainment System in Genetic Isolation Christian Diwo 1 and Nediljko Budisa 1,2,* 1 Institut für Chemie, Technische Universität Berlin Müller-Breslau-Straße 10, 10623 Berlin, Germany; [email protected] 2 Department of Chemistry, University of Manitoba, 144 Dysart Rd, 360 Parker Building, Winnipeg, MB R3T 2N2, Canada * Correspondence: [email protected] or [email protected]; Tel.: +49-30-314-28821 or +1-204-474-9178 Received: 27 November 2018; Accepted: 21 December 2018; Published: 28 December 2018 Abstract: The universal genetic code, which is the foundation of cellular organization for almost all organisms, has fostered the exchange of genetic information from very different paths of evolution. The result of this communication network of potentially beneficial traits can be observed as modern biodiversity. Today, the genetic modification techniques of synthetic biology allow for the design of specialized organisms and their employment as tools, creating an artificial biodiversity based on the same universal genetic code. As there is no natural barrier towards the proliferation of genetic information which confers an advantage for a certain species, the naturally evolved genetic pool could be irreversibly altered if modified genetic information is exchanged. We argue that an alien genetic code which is incompatible with nature is likely to assure the inhibition of all mechanisms of genetic information transfer in an open environment. The two conceivable routes to synthetic life are either de novo cellular design or the successive alienation of a complex biological organism through laboratory evolution.
    [Show full text]
  • Expanding the Genetic Code Lei Wang and Peter G
    Reviews P. G. Schultz and L. Wang Protein Science Expanding the Genetic Code Lei Wang and Peter G. Schultz* Keywords: amino acids · genetic code · protein chemistry Angewandte Chemie 34 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim DOI: 10.1002/anie.200460627 Angew. Chem. Int. Ed. 2005, 44,34–66 Angewandte Protein Science Chemie Although chemists can synthesize virtually any small organic molecule, our From the Contents ability to rationally manipulate the structures of proteins is quite limited, despite their involvement in virtually every life process. For most proteins, 1. Introduction 35 modifications are largely restricted to substitutions among the common 20 2. Chemical Approaches 35 amino acids. Herein we describe recent advances that make it possible to add new building blocks to the genetic codes of both prokaryotic and 3. In Vitro Biosynthetic eukaryotic organisms. Over 30 novel amino acids have been genetically Approaches to Protein encoded in response to unique triplet and quadruplet codons including Mutagenesis 39 fluorescent, photoreactive, and redox-active amino acids, glycosylated 4. In Vivo Protein amino acids, and amino acids with keto, azido, acetylenic, and heavy-atom- Mutagenesis 43 containing side chains. By removing the limitations imposed by the existing 20 amino acid code, it should be possible to generate proteins and perhaps 5. An Expanded Code 46 entire organisms with new or enhanced properties. 6. Outlook 61 1. Introduction The genetic codes of all known organisms specify the same functional roles to amino acid residues in proteins. Selectivity 20 amino acid building blocks. These building blocks contain a depends on the number and reactivity (dependent on both limited number of functional groups including carboxylic steric and electronic factors) of a particular amino acid side acids and amides, a thiol and thiol ether, alcohols, basic chain.
    [Show full text]
  • Biosynthesis of Ribosylthymine in the Transfer RNA of Streptococcus
    Proc. Nat. Acad. Sci. USA Vol. 72, No. 2, pp. 528-530, February 1975 Biosynthesis of Ribosylthymine in the Transfer RNA of Streptococcus faecalis: A Folate-Dependent Methylation Not Involving S-Adenosylmethionine (thymine/tRNA modification/formate/[methyl-'4Clmethionine/GlT'C-loop) ANN S. DELK AND JESSE C. RABINOWITZ Department of Biochemistry, University of California, Berkeley, Calif. 94720 Communicated by Bruce Ames, November 18, 1974 ABSTRACT Ribosylthymine is not present in tRNA of to produce thymidine 5'-monophosphate, which is sub- Streptococcus faecalis grown in the absence of folic acid, sequently used in DNA synthesis. Because of the folate although this methylated residue does occur in the tRNA of this organism when it is grown in the presence of folate. requirement for T formation in S. faecalis, it appeared possible We have found that, unlike other methylated residues in that methylation of RNA in this organism, particularly in RNA of S. faecalis and other organisms, the methyl moiety the biosynthesis of T, involves a folate derivative and not of ribosylthymine of the tRNA of folate-sufficient S. S-adenosylmethionine. faecalis is not derived from S-adenosylmethionine. Pre- liminary evidence suggests that a folate derivative serves MATERIALS AND METHODS as the methyl donor in this methylation. Unless stated otherwise, S. faecalis (ATCC 8043) and Esche- When grown in the presence of folic acid, Streptococcus richia coli (MRE 600) were grown for several generations in faecalis, like other prokaryotes, initiates protein synthesis
    [Show full text]
  • An Expanded Genetic Code in Mammalian Cells with a Functional Quadruplet Codon Wei Niu University of Nebraska-Lincoln, [email protected]
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by UNL | Libraries University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Faculty Publications -- Chemistry Department Published Research - Department of Chemistry 2013 An Expanded Genetic Code In Mammalian Cells With A Functional Quadruplet Codon Wei Niu University of Nebraska-Lincoln, [email protected] Peter G. Schultz The Scripps Research Institute Jiantao Guo University of Nebraska-Lincoln, [email protected] Follow this and additional works at: http://digitalcommons.unl.edu/chemfacpub Part of the Analytical Chemistry Commons, Medicinal-Pharmaceutical Chemistry Commons, and the Other Chemistry Commons Niu, Wei; Schultz, Peter G.; and Guo, Jiantao, "An Expanded Genetic Code In Mammalian Cells With A Functional Quadruplet Codon" (2013). Faculty Publications -- Chemistry Department. 101. http://digitalcommons.unl.edu/chemfacpub/101 This Article is brought to you for free and open access by the Published Research - Department of Chemistry at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Faculty Publications -- Chemistry Department by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. HHS Public Access Author manuscript Author Manuscript Author ManuscriptACS Chem Author Manuscript Biol. Author Author Manuscript manuscript; available in PMC 2015 July 14. Published in final edited form as: ACS Chem Biol. 2013 July 19; 8(7): 1640–1645. doi:10.1021/cb4001662. An Expanded
    [Show full text]
  • A Standard Reference Frame for the Description of Nucleic Acid Base-Pair Geometry Wilma K
    doi:10.1006/jmbi.2001.4987 available online at http://www.idealibrary.com on J. Mol. Biol. (2001) 313, 229±237 NOMENCLATURE A Standard Reference Frame for the Description of Nucleic Acid Base-pair Geometry Wilma K. Olson, Manju Bansal, Stephen K. Burley Richard E. Dickerson, Mark Gerstein, Stephen C. Harvey Udo Heinemann, Xiang-Jun Lu, Stephen Neidle, Zippora Shakked Heinz Sklenar, Masashi Suzuki, Chang-Shung Tung, Eric Westhof Cynthia Wolberger and Helen M. Berman # 2001 Academic Press Keywords: nucleic acid conformation; base-pair geometry; standard reference frame A common point of reference is needed to N1-C10 ÁÁÁC10 virtual angles consistent with values describe the three-dimensional arrangements of observed in the crystal structures of relevant small bases and base-pairs in nucleic acid structures. The molecules. Conformational analyses performed in different standards used in computer programs this reference frame lead to interpretations of local created for this purpose give rise to con¯icting helical structure that are essentially independent of interpretations of the same structure.1 For example, computational scheme. A compilation of base-pair parts of a structure that appear ``normal'' accord- parameters from representative A-DNA, B-DNA, ing to one computational scheme may be highly and protein-bound DNA structures from the unusual according to another and vice versa.Itis Nucleic Acid Database (NDB)4 provides useful thus dif®cult to carry out comprehensive compari- guidelines for understanding other nucleic acid sons of nucleic acid structures and to pinpoint structures. unique conformational features in individual struc- tures. In order to resolve these issues, a group of Base coordinates researchers who create and use the different soft- ware packages have proposed the standard base Models of the ®ve common bases (A, C, G, T reference frames outlined below for nucleic acid and U) were generated from searches of the crystal conformational analysis.
    [Show full text]
  • Advances in Oligonucleotide Drug Delivery
    REVIEWS Advances in oligonucleotide drug delivery Thomas C. Roberts 1,2 ✉ , Robert Langer 3 and Matthew J. A. Wood 1,2 ✉ Abstract | Oligonucleotides can be used to modulate gene expression via a range of processes including RNAi, target degradation by RNase H-mediated cleavage, splicing modulation, non-coding RNA inhibition, gene activation and programmed gene editing. As such, these molecules have potential therapeutic applications for myriad indications, with several oligonucleotide drugs recently gaining approval. However, despite recent technological advances, achieving efficient oligonucleotide delivery, particularly to extrahepatic tissues, remains a major translational limitation. Here, we provide an overview of oligonucleotide-based drug platforms, focusing on key approaches — including chemical modification, bioconjugation and the use of nanocarriers — which aim to address the delivery challenge. Oligonucleotides are nucleic acid polymers with the In addition to their ability to recognize specific tar- potential to treat or manage a wide range of diseases. get sequences via complementary base pairing, nucleic Although the majority of oligonucleotide therapeutics acids can also interact with proteins through the for- have focused on gene silencing, other strategies are being mation of three-dimensional secondary structures — a pursued, including splice modulation and gene activa- property that is also being exploited therapeutically. For tion, expanding the range of possible targets beyond example, nucleic acid aptamers are structured
    [Show full text]
  • Guide for Morpholino Users: Toward Therapeutics
    Open Access Journal of Drug Discovery, Development and Delivery Special Article - Antisense Drug Research and Development Guide for Morpholino Users: Toward Therapeutics Moulton JD* Gene Tools, LLC, USA Abstract *Corresponding author: Moulton JD, Gene Tools, Morpholino oligos are uncharged molecules for blocking sites on RNA. They LLC, 1001 Summerton Way, Philomath, Oregon 97370, are specific, soluble, non-toxic, stable, and effective antisense reagents suitable USA for development as therapeutics and currently in clinical trials. They are very versatile, targeting a wide range of RNA targets for outcomes such as blocking Received: January 28, 2016; Accepted: April 29, 2016; translation, modifying splicing of pre-mRNA, inhibiting miRNA maturation and Published: May 03, 2016 activity, as well as less common biological targets and diagnostic applications. Solutions have been developed for delivery into a range of cultured cells, embryos and adult animals; with development of a non-toxic and effective system for systemic delivery, Morpholinos have potential for broad therapeutic development targeting pathogens and genetic disorders. Keywords: Splicing; Duchenne muscular dystrophy; Phosphorodiamidate morpholino oligos; Internal ribosome entry site; Nonsense-mediated decay Morpholinos: Research Applications, the transcript from miRNA regulation; Therapeutic Promise • Block regulatory proteins from binding to RNA, shifting Morpholino oligos bind to complementary sequences of RNA alternative splicing; and get in the way of processes. Morpholino oligos are commonly • Block association of RNAs with cytoskeletal motor protein used to prevent a particular protein from being made in an organism complexes, preventing RNA translocation; or cell culture. Morpholinos are not the only tool used for this: a protein’s synthesis can be inhibited by altering DNA to make a null • Inhibit poly-A tailing of pre-mRNA; mutant (called a gene knockout) or by interrupting processes on RNA • Trigger frame shifts at slippery sequences; (called a gene knockdown).
    [Show full text]
  • A Synthetic DNA Built from Eight Building Blocks
    Foundation for Applied Molecular Evolution 13709 Progress Blvd Box 7, Alachua, FL 32615 A Synthetic DNA Built from Eight Building Blocks February 21, 2019 Alachua, FL – Life may be defined as a self-sustaining chemical system capable of Darwinian evolution. On Earth, humans use DNA to evolve, transferring information stored in its four building blocks first to RNA, and then to proteins. DNA and RNA are "universal" among known life forms on Earth. But are they truly universal, in life throughout the cosmos? An article published today in Science magazine suggests not. It reports a new kind of DNA, not from nature, but made in the lab by synthetic biologists. That new DNA doubles the four building blocks in natural DNA, making an 8-letter synthetic genetic system, called "hachimoji" DNA (from the Japanese "hachi" meaning "eight", and "moji" meaning "letter", as in "e-moji"). Hachimoji DNA can do everything that DNA does to support life. It pairs predictably, and rules predict its stability. Hachimoji DNA can be copied to make hachimoji RNA, able to direct protein synthesis. Hachimoji RNA can have a selectable phenotype, in this article, a green-fluorescent glow. Information storage, transmission, and selectable phenotype are three requirements of evolution. But there is a fourth: Structural regularity. "In 1942, Schrödinger predicted that no matter what genetic polymer life uses, its informational building blocks must all have the same shape and size," said Steven Benner, who led the team that created hachimoji DNA. Hachimoji meets this prediction. "Crystal structures of three different hachimoji DNA double helices reveal sequence-specific properties while retaining the essential features of natural DNA," said Millie Georgiadis, whose team at the Indiana University School of Medicine provided the crystal structures of hachimoji DNA.
    [Show full text]
  • De Novo Nucleic Acids: a Review of Synthetic Alternatives to DNA and RNA That Could Act As † Bio-Information Storage Molecules
    life Review De Novo Nucleic Acids: A Review of Synthetic Alternatives to DNA and RNA That Could Act as y Bio-Information Storage Molecules Kevin G Devine 1 and Sohan Jheeta 2,* 1 School of Human Sciences, London Metropolitan University, 166-220 Holloway Rd, London N7 8BD, UK; [email protected] 2 Network of Researchers on the Chemical Evolution of Life (NoR CEL), Leeds LS7 3RB, UK * Correspondence: [email protected] This paper is dedicated to Professor Colin B Reese, Daniell Professor of Chemistry, Kings College London, y on the occasion of his 90th Birthday. Received: 17 November 2020; Accepted: 9 December 2020; Published: 11 December 2020 Abstract: Modern terran life uses several essential biopolymers like nucleic acids, proteins and polysaccharides. The nucleic acids, DNA and RNA are arguably life’s most important, acting as the stores and translators of genetic information contained in their base sequences, which ultimately manifest themselves in the amino acid sequences of proteins. But just what is it about their structures; an aromatic heterocyclic base appended to a (five-atom ring) sugar-phosphate backbone that enables them to carry out these functions with such high fidelity? In the past three decades, leading chemists have created in their laboratories synthetic analogues of nucleic acids which differ from their natural counterparts in three key areas as follows: (a) replacement of the phosphate moiety with an uncharged analogue, (b) replacement of the pentose sugars ribose and deoxyribose with alternative acyclic, pentose and hexose derivatives and, finally, (c) replacement of the two heterocyclic base pairs adenine/thymine and guanine/cytosine with non-standard analogues that obey the Watson–Crick pairing rules.
    [Show full text]
  • CAS REGISTRY: Exact and Pattern Searching of Nucleic Acid Sequences
    CAS REGISTRYSM: Exact and pattern searching of nucleic acid sequences November 2008 Table of Contents Preface ........................................................................................................................................................ 3 Searching exact sequences ........................................................................................................................ 4 Using SEQLINK ........................................................................................................................................... 4 Searching partial sequences ....................................................................................................................... 6 Pattern searching ........................................................................................................................................ 7 Gaps ....................................................................................................................................................... 7 Repetition ................................................................................................................................................ 7 Other variability options .......................................................................................................................... 8 Order of execution for symbols ............................................................................................................... 8 Pattern searching example ....................................................................................................................
    [Show full text]
  • Identification of a 2-O-Methyluridine Nucleoside Hydrolase Using the Metagenomic Libraries
    molecules Article Identification of a 20-O-Methyluridine Nucleoside Hydrolase Using the Metagenomic Libraries Agota Auˇcynaite˙ 1,2, Rasa Rutkiene˙ 1, Daiva Tauraite˙ 1,2, Rolandas Meškys 1 and Jaunius Urbonaviˇcius 1,2,* 1 Department of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Life Sciences Center, Vilnius University, LT-10257 Vilnius, Lithuania; [email protected] (A.A.); [email protected] (R.R.); [email protected] (D.T.); [email protected] (R.M.) 2 Department of Chemistry and Bioengineering, Vilnius Gediminas Technical University, LT-10223 Vilnius, Lithuania * Correspondence: [email protected]; Tel.: +37-060-915-192 Received: 2 October 2018; Accepted: 4 November 2018; Published: 7 November 2018 Abstract: Ribose methylation is among the most ubiquitous modifications found in RNA. 20-O-methyluridine is found in rRNA, snRNA, snoRNA and tRNA of Archaea, Bacteria, and Eukaryota. Moreover, 20-O-methylribonucleosides are promising starting materials for the production of nucleic acid-based drugs. Despite the countless possibilities of practical use for the metabolic enzymes associated with methylated nucleosides, there are very few reports regarding the metabolic fate and enzymes involved in the metabolism of 20-O-alkyl nucleosides. The presented work focuses on the cellular degradation of 20-O-methyluridine. A novel enzyme was found using a screening strategy that employs Escherichia coli uracil auxotroph and the metagenomic libraries. A 20-O-methyluridine hydrolase (RK9NH) has been identified together with an aldolase (RK9DPA)—forming a part of a probable gene cluster that is involved in the degradation of 20-O-methylated nucleosides.
    [Show full text]